Dr. Yogisha brings 20 years of experience in discovery biology, medicinal chemistry, and pharmacology to the team, having been associated with leading drug discovery organizations. He has been involved in global sales, marketing, strategic partnerships, and R&D planning. In 2012, he founded the Skanda Life Sciences R&D center in Bangalore, India, with a passion for drug discovery in the areas of oncology, inflammation, metabolic disorders, and anti-microbials.
Prior to Skanda, Dr. Yogisha worked as General Manager at ATCC and as a Senior Principal Scientist at Jubilant Biosys in preclinical biology, where he was involved in several GPCR targets. He has led interdisciplinary drug discovery teams and provided leadership programs in various therapeutic areas, including oncology, osteoporosis, CNS, AD, anti-microbials, inflammation, respiratory, and metabolic disorders. He was also involved in G7 R&D and associated with biosimilar projects in Avesthagen on osteoporosis. He has extensive experience in vitro and in vivo assay development and validation.
Dr. Yogisha possesses strong project management skills and the ability to motivate research teams to deliver projects within budgets and timelines. He holds a Ph.D. in Microbiology from the University of Mysore and has numerous peer-reviewed publications. He is currently responsible for leading the Skanda business operations and investment in developing and strengthening capabilities and capacities.